CTOs on the Move


 
Heru Inc. (www.SeeHeru.com) has developed patented autonomous AI-powered vision diagnostics and augmentation software for commercially available AR/VR devices. This technology exceeds traditional standards of care in clinical equivalence, usability, cost, size and portability. Heru is the only cross-platform solution that can autonomously diagnose vision defects and customize individual vision augmentation based on the user`s unique vision defects.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.seeheru.com
  • 201, South Biscayne Boulevard
    Miami, FL USA 33132
  • Phone: 252.227.7013

Executives

Name Title Contact Details

Similar Companies

Ulab Systems

uLab has innovated the next generation of smile technology. Create aligner movement plans in as little as 10 minutes and print custom aligners the same day, right in your office.

Neurolens

Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.

Adhezion Biomedical

Adhezion Biomedical is a Hudson, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shared PET imagining

Shared PET imagining is a Canton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dasco Home Medical Equipment

Dasco Home Medical Equipment is a Westerville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.